Logo

NATR

Nature's Sunshine Products, Inc.

NATR

Nature's Sunshine Products, Inc. • NASDAQ
$20.58 ▲ 0.73% (+0.15)
Market Cap $360.06 M
52w High $21.64
52w Low $11.01
Dividend Yield 0%
P/E 25.41
Volume 40.52K
Outstanding Shares 17.50M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $128.339M ▲ $85.074M ▲ $5.334M ▲ 4.156% ▼ $0.3 ▲ $13.211M ▲
Q2-2025 $114.75M ▲ $78.025M ▲ $5.333M ▲ 4.647% ▲ $0.29 ▲ $11.068M ▲
Q1-2025 $113.248M ▼ $75.425M ▼ $4.747M ▲ 4.192% ▲ $0.26 ▲ $10.629M ▲
Q4-2024 $118.205M ▲ $80.514M ▲ $-321K ▼ -0.272% ▼ $-0.017 ▼ $7.051M ▼
Q3-2024 $114.615M $76.475M $4.347M 3.793% $0.23 $8.82M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $95.554M ▲ $264.805M ▲ $98.101M ▲ $160.502M ▲
Q2-2025 $81.345M ▼ $254.875M ▲ $91.193M ▲ $157.681M ▼
Q1-2025 $86.486M ▲ $252.702M ▲ $85.602M ▲ $161.285M ▲
Q4-2024 $84.7M ▲ $240.855M ▼ $79.864M ▼ $155.313M ▼
Q3-2024 $78.704M $245.333M $82.716M $156.528M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $5.334M ▼ $18.474M ▲ $-1.683M ▼ $-2.395M ▲ $14.209M ▲ $16.791M ▲
Q2-2025 $5.519M ▲ $4.34M ▲ $-1.35M ▼ $-12.122M ▼ $-5.141M ▼ $2.99M ▲
Q1-2025 $4.884M ▲ $2.609M ▼ $-1.11M ▲ $-731K ▼ $1.786M ▼ $1.499M ▼
Q4-2024 $-321K ▼ $12.184M ▲ $-2.195M ▼ $-576K ▲ $5.996M ▼ $9.989M ▲
Q3-2024 $4.347M $9.619M $-1.736M $-1.018M $10.009M $7.883M

Revenue by Products

Product Q1-2019Q1-2025Q2-2025Q3-2025
Personal Care Products
Personal Care Products
 $0 ▲$0 ▲$10.00M ▲$10.00M ▲
Natures Sunshine Products China
Natures Sunshine Products China
 $10.00M ▲$0 ▼$0 ▲$0 ▲
Natures Sunshine Products Russia Central And Eastern Europe
Natures Sunshine Products Russia Central And Eastern Europe
 $10.00M ▲$0 ▼$0 ▲$0 ▲
Synergy WorldWide
Synergy WorldWide
 $30.00M ▲$0 ▼$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has inched up over the last five years and has held fairly steady more recently, which suggests a mature but stable business rather than a fast‑growing one. Gross profitability looks solid for a packaged wellness company, indicating they keep a good share of each dollar of sales after product costs. However, operating profit and net income are relatively modest, and earnings have been a bit bumpy, with a weak year in the middle of the period followed by a rebound. Overall, the business appears consistently profitable but with thin cushions, so swings in costs, foreign exchange, or demand can quickly show up in the bottom line.

Balance Sheet

Balance Sheet The balance sheet looks conservative. The company keeps a meaningful amount of cash relative to its size and carries only a small amount of debt, which reduces financial risk. Assets and shareholder equity have been fairly stable over time, without signs of aggressive leveraging or rapid expansion. This points to a cautious financial posture: the business appears self‑funded, with room to withstand downturns, but not necessarily positioned for highly leveraged, rapid growth moves.

Cash Flow

Cash Flow Cash generation from day‑to‑day operations has generally been positive over the period, aside from a soft patch when operating performance dipped. After capital spending, free cash flow has usually remained positive, which is a healthy sign and suggests the company can support its investments and various corporate needs from internal cash. Capital expenditures have been modest and steady, indicating a focus on maintenance and targeted improvements rather than heavy, risky build‑outs. The main watchpoint is that, with relatively thin profits, cash flows can weaken quickly if sales or margins slip.

Competitive Edge

Competitive Edge Nature’s Sunshine occupies a specialized niche within supplements and wellness, built around quality, herbal expertise, and a long history in the field. Its direct‑selling model, supported by a large global network of independent distributors, gives it personal reach and loyalty that many retail‑focused brands lack. In‑house manufacturing and strict quality testing help differentiate its products and support premium positioning and trust. At the same time, the company operates in a very crowded and fast‑moving market, and the direct‑selling channel faces ongoing reputational and regulatory scrutiny, so sustaining this edge depends on constant support for distributors, brand building, and compliance.

Innovation and R&D

Innovation and R&D The dedicated Hughes Center for Research and Innovation is a notable strength, allowing Nature’s Sunshine to develop and clinically study proprietary formulas rather than relying on generic blends. This supports a pipeline of differentiated products, such as specialized herbal combinations and targeted wellness programs, and helps justify premium branding. Beyond product science, the company is investing in digital tools, personalized nutrition packs, and refreshed branding to modernize its image and better support its field sales network. The main execution risk is converting this scientific and digital investment into broad consumer awareness and faster product adoption in a noisy wellness landscape.

Summary

Nature’s Sunshine shows the hallmarks of a mature, niche wellness company: steady revenue, healthy gross margins, conservative use of debt, and generally positive cash flow, but with only modest profit levels and some earnings volatility. Its real strengths lie in brand legacy, strict quality control, proprietary research capabilities, and a large distributor network, which together form a defensible—though not unassailable—competitive position. Innovation is focused on science‑backed formulations, personalization, and digital tools, which align well with long‑term wellness trends. Key things to monitor are the company’s ability to translate these strengths into faster, more consistent earnings growth, manage the risks inherent in direct selling, and maintain product differentiation as the supplement market continues to crowd and evolve.

NEWS

November 6, 2025 · 4:05 PM UTC

Nature's Sunshine Reports Strong Third Quarter 2025 Results

Read more

October 23, 2025 · 4:05 PM UTC

Nature's Sunshine Sets Third Quarter 2025 Conference Call for Thursday, November 6, 2025, at 5:00 p.m. ET

Read more

October 15, 2025 · 9:00 AM UTC

Nature's Sunshine Appoints Kenneth Romanzi as CEO

Read more

October 7, 2025 · 4:05 PM UTC

Nature's Sunshine Relaunches Revolutionary Power Line to Combat Metabolic Health Crisis

Read more